Company news
Jiangsu Bioperfectus Technologies Co. Ltd. news in 2026
Jiangsu Bioperfectus Technologies Co. Ltd.'s news releases, calls and decks from 2026, newest first.
(688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Progress in the Freezing of Partnership Interests in the Controlling Shareholder Held by the Actual Controller and the Freezing of Certain Shares Held by the Controlling Shareholder
November 4, 2026
(688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Report for Q3 2026
October 23, 2026
(688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Use of Idle Self-owned Funds for Cash Management
October 23, 2026
(688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Use of Idle Raised Funds for Cash Management
October 23, 2026
(688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Re-appointment of Accounting Firm
October 23, 2026
(688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Provision for and Reversal of Asset Impairment for the First Three Quarters of 2026
October 23, 2026
(688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Judicial Freezing of Certain Shares Held by Controlling Shareholder
October 13, 2026
Announcement on Litigation Involving the Controlling Shareholder
October 13, 2026
(688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate
October 12, 2026
(688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Resolutions of the 18th Meeting of the 3rd Board of Directors
October 8, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
September 28, 2026
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate
September 24, 2026
Indicative Announcement on Change of the Executive Partner of the Partnership and Change in Equity Interests of Shareholders
September 21, 2026
Indicative Announcement on Postponement of Election of New Board of Directors
September 20, 2026
Announcement on Change in Accounting Policies
August 27, 2026
Indicative Announcement on the Termination of the Acting-in-Concert Relationship among Relevant Shareholders and the Change of the Actual Controller
July 29, 2026
Announcement on Implementation of Dividend Distribution for 2025
July 2, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 24, 2026
Announcement on Voluntary Disclosure of Changing Medical Device Registration Certificate
June 18, 2026
Notice on Convening the 2025 Annual General Meeting
June 3, 2026
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate
May 6, 2026
Report for Q1 2026
April 29, 2026
Announcement on 2025 Plan for Profit Distribution and Share Capital Increased from Transfer of Capital Reserve
April 22, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Earnings Preannouncement for 2025
January 30, 2026
Announcement on the Reversal of Bad Debt Provision for Some Accounts Receivable
January 18, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
January 5, 2026
Announcement on Obtaining Government Subsidies
January 4, 2026